Announcements Trials
Browse Landscape

Phase

Phase NA 221Phase 2 8Phase 3 4Phase 1 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 39Glioblastoma 37Glioma 33Prostatic Neoplasms 32Neoplasms 29Multiple Myeloma 25Pancreatic Neoplasms 24Brain Neoplasms 22Colorectal Neoplasms 18Recurrence 17Squamous Cell Carcinoma of Head and Neck 16Melanoma 15Lung Neoplasms 14Neoplasm Metastasis 13Lymphoma, B-Cell 13Carcinoma, Non-Small-Cell Lung 13Triple Negative Breast Neoplasms 12Sarcoma 12Lymphoma 12Hematologic Neoplasms 12Head and Neck Neoplasms 12Leukemia, Myeloid, Acute 11Advanced Solid Tumors 10Stomach Neoplasms 9Ovarian Neoplasms 9Lymphoma, Non-Hodgkin 9Skin Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neuroblastoma 8Colonic Neoplasms 8

Interventions

pembrolizumab 1cemiplimab 1beta-Glucans 1avelumab 1Nivolumab 1Ipilimumab 1Immune Checkpoint Inhibitors 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Motor Activity × 1 year × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT07305259 2025-12-26

REACT

Florida State University

Phase EARLY_PHASE1 Recruiting
60 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡